The COVID-19 global pandemic has had an acute impact on the healthcare industry and healthcare private equity investors. There are several issues directly affecting private healthcare companies on several fronts, 10 of which we have outlined in greater detail in our recent alert.
We recently hosted a “town hall” webinar, where co-chairs of our Healthcare Private Equity practice, Angela Humphreys and Ryan Thomas, moderated a panel with members from our COVID-19 Task Force to share best practices, the latest guidance, and address your questions as you seek to manage issues and ensure your portfolio companies are thoughtfully and proactively addressing concerns at this time of uncertainty and extreme market volatility.